TG Therapeutics Inc (TGTX)
35.07
+0.52
(+1.51%)
USD |
NASDAQ |
Nov 22, 16:00
35.35
+0.28
(+0.80%)
After-Hours: 20:00
TG Therapeutics Revenue (TTM): 264.79M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 264.79M |
| June 30, 2024 | 346.73M |
| March 31, 2024 | 289.33M |
| December 31, 2023 | 233.66M |
| September 30, 2023 | 189.77M |
| June 30, 2023 | 24.05M |
| March 31, 2023 | 8.571M |
| December 31, 2022 | 2.784M |
| September 30, 2022 | 5.025M |
| June 30, 2022 | 6.961M |
| March 31, 2022 | 7.912M |
| December 31, 2021 | 6.689M |
| September 30, 2021 | 4.406M |
| June 30, 2021 | 2.414M |
| March 31, 2021 | 0.907M |
| December 31, 2020 | 0.152M |
| September 30, 2020 | 0.152M |
| June 30, 2020 | 0.152M |
| March 31, 2020 | 0.152M |
| December 31, 2019 | 0.152M |
| September 30, 2019 | 0.152M |
| June 30, 2019 | 0.152M |
| March 31, 2019 | 0.152M |
| December 31, 2018 | 0.152M |
| September 30, 2018 | 0.152M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.152M |
| March 31, 2018 | 0.152M |
| December 31, 2017 | 0.152M |
| September 30, 2017 | 0.1517M |
| June 30, 2017 | 0.1518M |
| March 31, 2017 | 0.1519M |
| December 31, 2016 | 0.152M |
| September 30, 2016 | 0.1524M |
| June 30, 2016 | 0.1524M |
| March 31, 2016 | 0.1524M |
| December 31, 2015 | 0.1524M |
| September 30, 2015 | 0.1524M |
| June 30, 2015 | 0.1524M |
| March 31, 2015 | 0.1524M |
| December 31, 2014 | 0.1524M |
| September 30, 2014 | 0.1524M |
| June 30, 2014 | 0.1524M |
| March 31, 2014 | 0.1524M |
| December 31, 2013 | 0.1524M |
| September 30, 2013 | 0.1333M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.152M
Minimum
Dec 2019
346.73M
Maximum
Jun 2024
69.74M
Average
5.857M
Median
Revenue (TTM) Benchmarks
| ADMA Biologics Inc | 382.81M |
| Varex Imaging Corp | 811.00M |
| Rhythm Pharmaceuticals Inc | 112.53M |
| Inspire Medical Systems Inc | 755.59M |
| Mirum Pharmaceuticals Inc | 307.03M |